EMMA
Emmaus Life Sciences, Inc.
OTCHealthcareBiotechnologyUS
Rating:C+
Company Profile
CEO
Willis C. Lee
IPO Date
2000-05-09
Sector
Healthcare
Industry
Biotechnology
Exchange
OTC
Country
US
Emmaus Life Sciences, Inc.
CEO
Willis C. Lee
IPO Date
2000-05-09
Sector
Healthcare
Industry
Biotechnology
Exchange
OTC
Country
US
| $0.00 |
| 29 Feb 2024 | LEE WILLIS C | director, officer: Co-President & COO | P-Purchase | Acquired | 77,000 | $0.13 |
| 29 Feb 2024 | LEE WILLIS C | director, officer: Co-President & COO | P-Purchase | Acquired | 15,000 | $0.12 |
| 29 Feb 2024 | LEE WILLIS C | director, officer: Co-President & COO | P-Purchase | Acquired | 10,000 | $0.13 |
| 29 Feb 2024 | LEE WILLIS C | director, officer: Co-President & COO | P-Purchase | Acquired | 13,200 | $0.12 |
| 5 Feb 2024 | LEE WILLIS C | director, officer: Co-President & COO | A-Award | Acquired | 200,000 | $0.15 |
| 5 Feb 2024 | ZEN Wei Peu | director | A-Award | Acquired | 100,000 | $0.15 |
| 3 Jan 2024 | LEE WILLIS C | director, officer: COO | P-Purchase | Acquired | 59,400 | $0.12 |
| 3 Jan 2024 | LEE WILLIS C | director, officer: COO | P-Purchase | Acquired | 36,000 | $0.12 |